Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
Study examining the effect of different diuretics on fluid retention in diabetics treated with rosiglitazone.
Non-Insulin-Dependent Diabetes Mellitus
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||See Detailed Description|
- Changes in Haematocrit following 7 days diuretic adminstration.
- Total body fluid & extracellular fluid, body weight, haematocrit & haemoglobin.
|Study Start Date:||October 2002|
A randomised, open-label, parallel group study to evaluate the management of rosiglitazone-related fluid retention by investigating the effect of diuretics on plasma volume in subjects with type 2 diabetes mellitus treated for twelve weeks with rosiglitazone 4mg bd in addition to background anti-diabetic agents.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00306696
Show 44 Study Locations
|Study Director:||GSK Clinical Trials||GlaxoSmithKline|